Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
—1,100.611,106.151,114.281,098.89——
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
—612.30612.30616.40612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
—644.73645.31649.16642.15——
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
—827.09828.05833.90827.27——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
—214.82214.82216.61212.62——
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
—3,115.173,142.773,186.203,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
—910.43915.18923.94906.03——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
—1,474.501,480.841,491.461,475.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
—2,405.872,415.572,420.792,398.99——
I9DN:FRA
Arbutus Biopharma Corp
€3.72
-3.38%
(-0.13) 1D
Apr 22, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for I9DN...
Open
€3.72
High
€3.72
Low
€3.72
Mkt. cap
872.44M
Avg. vol.
965.00
Volume
0.00
52-wk high
€4.31
52-wk low
€2.56
No. of employees
19
News stories
From sources across the web
Profile
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
About Arbutus Biopharma Corp
CEOWilliam H. Collier
Employees19
Founded2007
HeadquartersWarminster Township, Pennsylvania, United States
SectorBiotechnology
Websitearbutusbio.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.76M
10.74M
529.00K
1.05M
Cost of goods sold
8.96M
5.50M
5.78M
5.01M
Cost of revenue
8.96M
5.50M
5.78M
5.01M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.83M
3.33M
3.04M
3.69M
Operating expense
5.83M
3.33M
3.04M
3.69M
Total operating expenses
14.79M
8.83M
8.82M
8.70M
Operating income
-13.03M
1.91M
-8.29M
-7.64M
Other non operating income
-
-
-
-
EBT including unusual items
-24.53M
2.52M
-7.74M
-3.76M
EBT excluding unusual items
-11.85M
2.95M
-7.38M
-6.78M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24.53M
2.52M
-7.74M
-3.76M
Net profit margin
-1,390.36%
23.49%
-1,463.52%
-357.37%
Earnings per share
-
-
-
-
Interest and investment income
1.20M
1.04M
952.00K
877.00K
Interest expense
-28.00K
-28.00K
-23.00K
-18.00K
Net interest expenses
1.17M
1.01M
929.00K
859.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.70M
1.92M
-8.28M
-7.63M
Gain or loss from assets sale
-
-
-
-674.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer